4//SEC Filing
Catelani Michael 4
Accession 0001493152-21-010447
CIK 0000715446other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 6:15 PM ET
Size
5.6 KB
Accession
0001493152-21-010447
Insider Transaction Report
Form 4
Catelani Michael
President, COO & CFO
Transactions
- Other
Common Stock
2021-04-30$1.84/sh+1,634$3,007→ 9,383 total
Footnotes (2)
- [F1]The reporting person purchased the shares of common stock reported hereunder pursuant to the Anixa Biosciences, Inc. Employee Stock Purchase Plan (the "Plan") which satisfies the requirements of Section 423 of the Internal Revenue Code. The reporting person's purchase of the shares of common stock is exempt from Section 16(b) under Rule 16b-3(c) and is exempt from the reporting requirements of Section 16 by virtue of Rule 16a-3(f)(1)(i)(B), however the reporting person has elected to voluntarily report the acquisition of the shares.
- [F2]In accordance with the Plan, the shares were purchased based on 85% of the closing price of Anixa Biosciences, Inc. common stock on November 2, 2020.
Documents
Issuer
Anixa Biosciences Inc
CIK 0000715446
Entity typeother
Related Parties
1- filerCIK 0001689394
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 6:15 PM ET
- Size
- 5.6 KB